Legislative Progress
Introduced
September 24, 2026
Latest Action
September 24, 2026
Primary Sponsor
Mark R. WarnerDemocratic(VA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · third_quarter · Medicare/Medicaid
S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S.927, the Protecting Pharmacies in Medicaid Act; H.R.3164/S.2426, the Mainstreet Pharmacy Access Act/the Ensuring Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)' H.R.1, the One Big Beautiful Bill Act Comments to CMS on "Re: Draft Guidance for IPAY 2028 and Manufacturer Effectuation of the MFP for 2026, 2027, and 2028 for the Medicare Drug Price Negotiation Program"; Comments to CMS on "Re: Medicare Transaction Facilitator DRAFT Standard Companion Guide Health Care Claim Payment/Advice (835)" Comments to CMS on "Re: Agency Information Collection Activities: Proposed Collection; Comment Request [Docket No. CMS-10912] - CMS-10912 Medicare Transaction Facilitator for 2026 and 2027 under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) - Drug Price Negotiation Program MTF DM Dispensing Entity and Third-Party Support Enrollment Form"; H.Con.Res.14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; H.R.4317, the PBM Reform Act; H.R.5031/S.3159, the Preserving Patient Access to Long-Term Care Pharmacies Act; Comments to CMS on "RE:Re: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model [CMS-1830-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies [CMS-1828-P]"; Comments to CMS on "RE:Re: 340B Program Notice: Application Process for the 340B Rebate Model Pilot Program [HRSA2025 and HRSA-2025-14619]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1832-P]"; H.R.5256, the 340B ACCESS Act; S.2800, the Pharmacy and Medically Underserved Areas Enhancement Act; S.3345, the PBM Price Transparency and Accountability Act; H.R. 6609, Pharmacists Fight Back in Medicare and Medicaid Act; Grassley-Lujan Request-for-Information on Pharmacists Providing Chronic Care; CMMI Potential reimbursement model for CMS coverage of GLP-1 drugs; H.R.7148, the Consolidated Appropriations Act, 2026; Comments to CMS on Proposed Rule "Re: Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program"; Implementation of "reasonable and relevant" contract terms in the Medicare Part D Program; Comments to CMS on "Re: Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges [CMS-0062-P]"; Comments to CMS on "Re: Medicare GLP-1 Bridge Program - Improper Restriction of the $5.00 LTC Dispensing Fee to Nursing Facility and ICF/IID Residents; Conflict with 42 C.F.R. 423.120, Chapter 5, Section 20.7 of the Medicare Prescription Drug Benefit Manual, and CMSs December 15, 2021 Guidance on LTC Pharmacy Access"; Comments to CMS on "Re: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program [CMS-4215-P]"; Comments to CMS on "Re: Medicare and Medicaid Programs; CY 2027 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings [CMS-1848-P]"; S. 5496, Health CARE Act of 2026; S. 5586, Ensuring Accurate Payments to Specialty Pharmacies Act
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $370,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Health Issues
H. Res 1519 - Supporting the Designation of September 17, 2026 as National Physician Suicide Awareness Day to Raise Awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes. H. Res. 1528 - Recognizing Suicide as a serious public health problem and expressing support for the designation of September 2026 as National Physician Suicide Prevention Month, as well as September 10, 2026 as World Suicide Prevention Day. H.R. 1 - One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI), provisions related to changes in medicaid regarding "Release the Pressure" hypertension control campaign H.R. 1254 - Rural Obstetrics Readiness Act, all provisions H.R. 2314 - Fair Access In Residency (FAIR) Act, all provisions H.R. 3492 - Protect Children's Innocence Act, all provisions H.R. 9390 - Prices on the Wall Act, all provisions H.R. 9395 - Transparency in Medicare Advantage Steering Act, all provisions H.R. 9645 - Health Care Price Certainty for All Americans Act, all provisions H.R. 9693 - The Patients First Act of 2026 - all provisions H.R.10444 - The Stop Corporate Takeovers of Physicians Act, all provisions H.R.1520 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R.2191 - Physician Led and Rural Access to Quality Care Act, all provisions H.R.2332 - SHARE Act of 2025, all provisions H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R.2850 - Youth Sports Facilities Act of 2025, all provisions H.R.3022 - Restoring Rights of Physicians to Own Hospitals Act, all provisions H.R.3164 - Ensuring Community Access to Pharmacist Services Act, all provisions H.R.3170 - Improving Access to Workers Compensation for Injured Federal Workers Act of 2025, all provisions H.R.4583 - Living Donor Protection Act of 2025, all provisions H.R.4710 - No Surprises Act Enforcement Act, all provisions H.R.5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions H.R.5861 - Legacy Act of 2025, all provisions H.R.628 - Honor Our Living Donors Act, all provisions H.R.7023 - Affordable CHOICE Act, all provisions H.R.7868 - Expanding Support for Living Donors Act of 2026, all provisions H.R.7884 - Healthcare is Human Act of 2026, all provisions H.R.8794 - FED UP with Bleeding Disorders Act of 2026, all provisions H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.929 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions H.R.9393 - Lower Costs, More Transparency Act of 2026, all provisions H.R.9396 - Prior Authorization Accountability Act, all provisions S. 380 - Rural Obstetrics Readiness Act, all provisions S.1390 - Physician Led and Rural Access to Quality Care Act, all provisions S.1419 - Youth Sports Facilities Act of 2025, all provisions S.1552 - Living Donor Protection Act of 2025, all provisions S.1782 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S.2355 - Patients Deserve Price Tags Act, all provisions S.2420 - No Surprises Act Enforcement Act, all provisions S.2426 - Equitable Community Access to Pharmacist Services , all provisions S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S.3097 - Health Information Privacy Reform Act, all provisions S.3315 - Health Care Cybersecurity and Resiliency Act of 2026, all provisions S.3599 - Affordable CHOICE Act, all provisions S.3907 - Health Information Privacy Reform Act, all provisions S.5419 - The Stop Corporate Takeovers of Physicians Act, all provisions S.5496 - Health for the Commonwealth through Affordability Reform and Expansion Health Care (CARE) Act, all provisions "Legitimate Medical Purpose" definition under the Controlled Substance Act "Still at Risk" wristband initiative Jeanette Acosta Invest in Women's Health Act Comment Letter: [ACF-2026-0595] Reducing Federal Burden for Head Start Programs Comment Letter: [CMS-2026-1255-0001] Medicare and Medicaid Programs: Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, etc. Comment Letter: [REG-118484-25; CMS-9879-P; RIN 0938-AV94; RIN 1210-AC40; RIN 1545-BS02] Excepted Fertility Benefits Comment Letter: Request for Information (RFI) on Health Coverage that Works for Everyone Comment Letter: [2120-AM18] Improving Emergency Medical Kit Efficacy and Flexibility in Commercial Airline Operations Draft: Health Infrastructure Security and Accountability Act Draft: Noncompete clauses in physician contracts Matters related to AI use in prior authorization Matters related to Alternative Payment Model bonuses/incentive payments and freezing the qualifying provider revenue thresholds Matters related to Data privacy, cybersecurity, and AI Matters related to Health care consolidation Matters related to the Health Insurance Portability and Accountability Act (HIPAA) and electronic records Matters related to Maternal health and hypertensive disorder during pregnancy Matters related to Medical devices Matters related to Nutrition Matters related to the Office of the National Coordinator for Health Information Technology (ONC) improving electronic health record certification; implementation of 21st Century Cures Act provisions; digital health policies, and reduction of technology burden on physicians entering into the Quality Payment Program Matters related to Payment for AI services within health care Matters related to the Public Health effects of opioid medications Matters related to Unbundling of Maternity Care of Current Procedural Terminology (CPT) Codes Matters related to the United States Preventive Services Task Force (USPSTF) Matters related to Vaccines/ACIP Matters related to ACA benefits and payments Matters related to high-resolution anoscopy services Matters related to peptides Matters related to physician prescribing of antibiotics Matters related to reproductive health Matters related to the Authorization of ENDS Products Age Verification
Client expense: $4,540,000 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of